Turn Therapeutics Inc., operates as a pharmaceuticals company that develops drugs to treat diseases of the skin, nails, and eye. The company's delivery technology penetrates the skin and nails and reduces antibiotic through acute and chronic wound care products, enabling healthcare institutions to care for a variety of skin conditions, ranging from acute to chronic wounds, skin conditions, and dermatoses. The company was formerly known as Global Health Solutions, Inc and change its name to Turn Therapeutics Inc. in September 2025. Turn Therapeutics Inc. was incorporated in 2015 and is based in Westlake Village, California. Show more

250 N Westlake Blvd, Westlake Village, CA, 91362, United States

Biotechnology

Healthcare

Market Cap

307M

52 Wk Range

$2.57 - $26.50

Previous Close

$10.11

Open

$10.10

Volume

62,760

Day Range

$9.47 - $10.28

Enterprise Value

288.3M

Cash

0.00

Avg Qtr Burn

N/A

Insider Ownership

53.88%

Institutional Own.

3.87%

Qtr Updated

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
GX-03 Details Atopic dermatitis	Phase 2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
GX-03 (IL-36 Inhibitor) Details Hidradenitis suppurativa	Phase 2a Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.